Read + Share
Miyamura K, Ito M, Yamaoka H, Hisakado M, et al. Impact of minimal dose strategy before anti-thyroid drug discontinuation on
relapse risk in Graves' disease. J Clin Endocrinol Metab 2025 Aug 1:dgaf433. doi: 10.1210.
PMID: 40746193
|
 |
|
Miyamura K, Ito M, Yamaoka H, Hisakado M, et al. Impact of minimal dose strategy before anti-thyroid drug discontinuation on
relapse risk in Graves' disease. J Clin Endocrinol Metab 2025 Aug 1:dgaf433. doi: 10.1210.
PMID: 40746193
|
|
|
|